CTIC — CTI Biopharma Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- $1.20bn
- $1.26bn
- $53.95m
CTI Biopharma Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: CTI Biopharma To Report Fourth Quarter 2022 Results On March 6, 2023
Brief: CTI BioPharma Corp Reports Q3 Loss Per Share Of $0.13
CTI Biopharma Corp reports results for the quarter ended in September - Earnings Summary
CTI Biopharma Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: CTI Biopharma Announces Presentation Of New Anemia Benefit Data From Pacritinib Program
U.S. STOCKS ON THE MOVE-Pfizer, Nvidia, Boeing, SAIC, BioAffinity, Polestar
U.S. STOCKS ON THE MOVE-Kroger, J.Jill, Twin Disc, Abbvie
U.S. STOCKS ON THE MOVE-Arcturus, Five Below, Mullen
U.S. STOCKS ON THE MOVE-Nvidia, Nutanix, Comera, chip stocks
Jefferies cheers CTI BioPharma's bone marrow cancer drug
U.S. RESEARCH ROUNDUP- CTI Biopharma, PayPal Holdings, Shattuck Labs
Brief: CTI Biopharma Corp Files For Mixed Shelf Of Up To $200 Million - SEC Filing
U.S. STOCKS ON THE MOVE-Atara Bio, Novavax, Micron, Norwegian Cruise
U.S. STOCKS ON THE MOVE-Applied DNA, Verona Pharma, SELLAS
U.S. STOCKS ON THE MOVE-Capri Holdings, Mersana, Vivid Seats
U.S. STOCKS ON THE MOVE-Boeing, Occidental Petroleum, Bed Bath & Beyond
CTI BioPharma falls after bigger-than-expected loss
Brief: Cti Biopharma Q2 Loss Per Share $0.21